arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Barinthus Biotherapeutics plc.

BRNS

$0.75 0.00 (0.00%) at close

26 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Barinthus Biotherapeutics plc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $30.6M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -19.3% ↘

FCF / Share $-0.20 ↘

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 8, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-10.58M

↑ +49.9% —

Operating Margin Operating profit as % of sales

-62.7%

↑ +83.9% —

FCF / Share Free cash flow per share

$-0.20

↓ -140.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Revenue Growth YoY (%)	—	—	—	N/M	—	—	—	—	N/M	N/M	N/M	—	-98.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1326%)	-96.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1311%)	N/M	32347.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+404242%)	48651.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+608043%)	6885.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+85964%)	N/M	-99.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1343%)	-93.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1264%)	-69.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-969%)	—	—	—	—
EPS Growth YoY (%)	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	71.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	47.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-71.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-20.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-22.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-13.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	43.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good Good Year-over-year change in earnings per share Optimal: > 10%	21.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	N/M	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	71.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—
Net Income Growth YoY (%)	49.9% Excellent ↑ Excellent Improving Year-over-year change in net income	71.8% Excellent ↑ Excellent Improving Year-over-year change in net income	46.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-79.5% Weak ↓ Weak Declining Year-over-year change in net income	-24.8% Weak ↓ Weak Declining Year-over-year change in net income	-26.9% Weak ↓ Weak Declining Year-over-year change in net income	-18.8% Weak ↓ Weak Declining Year-over-year change in net income	42.3% Excellent ↑ Excellent Improving Year-over-year change in net income	28.9% Excellent ↑ Excellent Improving Year-over-year change in net income	14.8% Fair Fair Year-over-year change in net income	18.4% Good Good Year-over-year change in net income	N/M	N/M	N/M	-40.2% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-44.6% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-343.9% Weak Weak Year-over-year change in net income	-299.6% Weak Weak Year-over-year change in net income	—	—	—	—
FCF Growth YoY (%)	—	77.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-18.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-109.3% Weak Weak Year-over-year change in free cash flow	—	—	—	27.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	823.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	-13.2% Weak Weak Compound annual revenue growth over 3 years	-12.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	-62.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-518%)	—	—	—	—	—	—	-388.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2691%)	—	80.8% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+439%)	4.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-71%)	—	—	—	—	—	-43.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-393%)	—	—
Effective Tax Rate (%) (%)	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	-54.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-552%)	—	—	—	—	—	—	-328.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2835%)	—	92.0% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+666%)	17.3% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+44%)	—	—	—	—	—	4.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-59%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-184.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-51.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	-27.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-194.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.95x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-5.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair Fair Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Return on Invested Capital (%)	-19.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	4.3% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	-5.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-13.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	4.8% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-3.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-19.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-18.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-8.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	-14.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-17.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-20.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	-17.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-213%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-5.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	-10.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-9.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-7.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	6.2% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-59%)	—	-6.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-1409.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-2300.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1881.21x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	8.84x Good Good Operating income divided by interest expense Optimal: > 5x	-926.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-2.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1.47x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-59.30M	$-65.86M	$-70.46M	$-74.27M	$-86.26M	$-99.12M	$-110.66M	—	—	—	$-142.09M	$-160.31M	$-173.03M	$-191.33M	$-194.38M	$-200.10M	$-192.33M	$-200.60M	$-214.05M	$-233.87M	—	$-155.94M	$-43.27M	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Revenue per Share (USD)	—	—	—	$0.00	—	—	—	$0.38	$0.00	$0.00	—	—	$0.01	$0.01	—	$0.17	$0.46	$0.40	—	$0.00	$0.00	—	—	$0.41	—	—
Basic EPS, GAAP (USD)	$-0.26	$-0.14	$-0.27	$-0.36	$-0.52	$-0.49	$-0.51	$-0.21	$-0.43	$-0.40	$-0.45	$-0.37	$-0.62	$-0.48	$-0.57	$0.22	$0.42	$0.07	$-0.38	$-0.13	$-0.64	—	$-1.32	$0.02	—	—
Free Cash Flow per Share (USD)	$-0.20	$-0.08	—	$-0.26	—	$-0.37	—	—	—	$-0.31	—	—	—	$-0.15	—	—	—	$-0.21	—	—	$-0.60	—	—	$-0.11	—	—
Book Value per Share (USD)	$1.40	$1.63	$1.82	$2.07	$2.54	$2.86	$3.23	$4.03	$4.00	$4.41	$4.83	$5.07	$5.64	$6.08	$6.45	$6.54	$6.84	—	$6.78	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$1.08	$1.29	$1.47	$1.70	$2.03	$2.34	$2.69	$3.14	$3.08	$3.47	$3.87	$4.08	$4.63	$5.05	$5.37	$5.42	$5.69	—	$5.59	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	40.85M	40.85M	—	40.66M	40.34M	40.27M	—	39.42M	39.04M	38.77M	—	38.53M	38.41M	38.01M	—	37.25M	37.20M	37.19M	—	34.84M	24.90M	—	—	7.94M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Working Capital (USD)	$51.85M	$60.66M	$67.77M	$75.98M	$87.69M	$97.91M	$110.08M	$119.58M	$116.29M	$130.30M	$144.31M	$152.50M	$172.67M	$188.68M	$200.80M	$204.59M	$214.12M	$214.30M	$215.61M	$239.61M	—	$154.72M	$40.26M	—	—	—
Total Equity (USD)	$57.07M	$66.40M	$74.21M	$84.47M	$102.38M	$115.49M	$130.03M	$159.29M	$156.62M	$171.83M	$186.78M	$195.40M	$217.21M	$233.30M	$242.90M	$243.84M	$254.40M	—	$252.12M	—	—	—	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗
Sales/Revenue/Turnover (USD)	—	—	$0.00	$0.00	—	—	$0.00	$14.97M	$0.00	$0.00	$0.00	—	$334.00K	$468.00K	$6.46M	$6.17M	$17.06M	$15.02M	$-1.00K	$19.00K	$35.00K	$215.00K	$354.00K	$3.25M	$511.00K	$705.00K
Depreciation Expense (USD)	$820.00K	$856.00K	$909.00K	$901.00K	$1.20M	$2.03M	$1.43M	$700.00K	$700.00K	$1.43M	$1.44M	$700.00K	$500.00K	$1.22M	$1.18M	—	—	$966.00K	$321.00K	—	$104.00K	$92.00K	$56.00K	$55.00K	$48.00K	$49.00K
Net Income, GAAP (USD)	$-10.58M	$-5.53M	$-11.09M	$-14.57M	$-21.12M	$-19.65M	$-20.54M	$-8.11M	$-16.93M	$-15.49M	$-17.29M	$-14.07M	$-23.80M	$-18.18M	$-21.19M	$8.24M	$15.69M	$2.60M	$-15.11M	$-4.56M	$-15.93M	$-15.27M	$-10.46M	$158.00K	$-3.59M	$-3.82M
Operating Cash Flow (USD)	$-8.09M	$-3.37M	$-4.24M	$-10.73M	—	$-14.90M	$13.09M	—	—	$-11.82M	$-19.60M	—	—	$-3.17M	$-11.34M	—	—	$-6.58M	$-7.97M	—	$-14.62M	$-7.97M	$-4.90M	$-861.00K	$-950.00K	$-4.32M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 26 quarters

Barinthus Biotherapeutics plc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BRNS with peers